A transgenic model of visceral obesity and the metabolic syndrome.
about
Green tea and one of its constituents, Epigallocatechine-3-gallate, are potent inhibitors of human 11β-hydroxysteroid dehydrogenase type 1HIV-associated adipose redistribution syndrome (HARS): etiology and pathophysiological mechanismsAppropriate function of 11beta-hydroxysteroid dehydrogenase type 1 in the endoplasmic reticulum lumen is dependent on its N-terminal region sharing similar topological determinants with 50-kDa esterase"Control" laboratory rodents are metabolically morbid: why it mattersEmodin, a natural product, selectively inhibits 11beta-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese miceDNA binding-dependent glucocorticoid receptor activity promotes adipogenesis via Krüppel-like factor 15 gene expressionCortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humansRole of visceral adipose tissue in agingGlucocorticoid regulation of the circadian clock modulates glucose homeostasisThe biological actions of dehydroepiandrosterone involves multiple receptorsRole of glucocorticoids in mediating effects of fasting and diabetes on hypothalamic gene expressionThe role of glucocorticoid action in the pathophysiology of the Metabolic SyndromeAdrenalectomy stimulates hypothalamic proopiomelanocortin expression but does not correct diet-induced obesityDimerization and enzymatic activity of fungal 17beta-hydroxysteroid dehydrogenase from the short-chain dehydrogenase/reductase superfamily.Exercise Regulation of Marrow Adipose TissueImpact of Glucocorticoid Excess on Glucose Tolerance: Clinical and Preclinical EvidenceIdiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenasesRelationships between Rodent White Adipose Fat Pads and Human White Adipose Fat DepotsInteractions between sleep, stress, and metabolism: From physiological to pathological conditionsPharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid DehydrogenasesEndocrine causes of nonalcoholic fatty liver diseaseAdipogenesis is under surveillance of Hsp90 and the high molecular weight Immunophilin FKBP51Enzymatic intracrine regulation of white adipose tissueModulation of 11β-hydroxysteroid dehydrogenase as a strategy to reduce vascular inflammationModulation of glucose metabolism by the renin-angiotensin-aldosterone system11β-hydroxysteroid dehydrogenase type 1 gene knockout attenuates atherosclerosis and in vivo foam cell formation in hyperlipidemic apoE⁻/⁻ miceMutations of key hydrophobic surface residues of 11β-hydroxysteroid dehydrogenase type 1 increase solubility and monodispersity in a bacterial expression systemAn intact eight-membered water chain in drosophilid alcohol dehydrogenases is essential for optimal enzyme activityOptimization of 1,2,4-Triazolopyridines as Inhibitors of Human 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD-1)The Metabolic Implications of Glucocorticoids in a High-Fat Diet Setting and the Counter-Effects of Exercise'Striking the Right Balance' in Targeting PPARgamma in the Metabolic Syndrome: Novel Insights from Human Genetic StudiesCortisol metabolism and visceral obesity: role of 11beta-hydroxysteroid dehydrogenase type I enzyme and reduced co-factor NADPHSalicylate downregulates 11β-HSD1 expression in adipose tissue in obese mice and in humans, mediating insulin sensitizationThe endocrine function of adipose tissue: an updateWhat is metabolic syndrome, and why are children getting it?Curcumin as a potent and selective inhibitor of 11β-hydroxysteroid dehydrogenase 1: improving lipid profiles in high-fat-diet-treated ratsRegular exercise prevents the development of hyperglucocorticoidemia via adaptations in the brain and adrenal glands in male Zucker diabetic fatty ratsPostnatal maternal separation modifies the response to an obesogenic diet in adulthood in ratsIncreased 11beta-hydroxysteroid dehydrogenase type-1 and hexose-6-phosphate dehydrogenase in liver and adipose tissue of rat offspring exposed to alcohol in uteroEvidence that the 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD1) is regulated by pentose pathway flux. Studies in rat adipocytes and microsomes
P2860
Q21089692-53FD4DBF-D6AE-4B9D-BFF3-853DB2B5D402Q21245028-65FC335E-6A82-44BA-845E-E3AEFE55DAAFQ24293608-6F706CB8-0FF0-41D9-B5DC-C827096F65DFQ24599731-7ED1CEC4-DFF2-438D-B609-9D811762783BQ24627436-FBA247F9-6F3D-458A-82E1-0E37F06D8254Q24634129-D792717A-6C07-4722-B48B-D02A595DC4A4Q24642463-3161181C-2BFB-4036-83A1-ED6289440BADQ24654243-5791A4CA-7E00-4FE9-BE33-2E55F1E41149Q24657351-72EC46A2-83C5-4768-8537-9A1529487088Q24657968-A27BB0CD-B132-45DC-B4ED-73BB82920099Q24793433-906E0F61-88AE-4B57-905D-706F1F7CFFA4Q24803696-8D35C2C2-15F0-441B-A349-D748C6A7DA1CQ24805593-5166F8CC-E34D-48C3-A976-191E31B895ECQ25256625-1ADD797C-48AF-4869-B982-0AF6A2EB7281Q26740675-01D05053-4ED6-4B3B-87EA-F1602D4D4FF5Q26741374-6A84FE07-FE7B-4BDE-A31D-C9964984CB4EQ26749288-9CD82AAB-A8FA-4C7F-8F42-DCF9E3F0041FQ26752318-235CDA3C-A4CC-4F58-BCED-A68936CEE113Q26771412-54D2D0AB-7986-4B19-BC10-E237E3856416Q26772046-A18F3207-16BC-4B8D-85D0-D5E628C2FFCAQ26780254-01B41E7D-4B8C-4D68-A1CE-F74881EF675AQ26785555-DDCDD7E2-07C4-447D-B28B-9E77C18E013CQ26851926-A467C12F-2DA7-4529-BF42-C6D973034AA4Q26998660-DF4E7727-64BB-4D24-B845-5F3291B2F4C6Q27026157-07CA64C8-445E-4108-9BD8-EE92D0C51C0EQ27322801-B30F798F-7EF2-495A-BD40-64BCC1BADCE7Q27655825-49AF6E51-B60A-420C-85C7-40936E618AEBQ27681631-F459A20C-D424-482F-A0FA-187D1DCCAF1CQ27684779-664EE2AE-C32B-484F-8161-93B6C5BE76A6Q28076700-2BEA5B1F-58E7-4958-AEBF-22B7083D6318Q28221639-FDCD88F9-85D8-4522-9E52-DF08017416E4Q28235040-0844F93B-2362-432B-90E9-125A91CBDFEFQ28260504-58EA272A-42D8-48C1-B542-BBC40924E041Q28305131-63FB2CC6-80B9-4F52-9B2E-109F585668DDQ28385817-02217320-1622-4E5A-837B-C05CC9723704Q28488754-DDF3078A-2741-4D48-82C4-6E54C8489A50Q28575844-33DB70E6-1CDB-4EEF-A642-66A2A85CA431Q28577137-0502B871-9D07-4156-A9F1-B31FED1D0F0FQ28578232-95A453CE-D398-4103-B658-F95F04B2C86BQ28582249-9749FD24-DFA2-45E4-A9EF-4E3C195BFD3A
P2860
A transgenic model of visceral obesity and the metabolic syndrome.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
A transgenic model of visceral obesity and the metabolic syndrome.
@ast
A transgenic model of visceral obesity and the metabolic syndrome.
@en
A transgenic model of visceral obesity and the metabolic syndrome.
@nl
type
label
A transgenic model of visceral obesity and the metabolic syndrome.
@ast
A transgenic model of visceral obesity and the metabolic syndrome.
@en
A transgenic model of visceral obesity and the metabolic syndrome.
@nl
prefLabel
A transgenic model of visceral obesity and the metabolic syndrome.
@ast
A transgenic model of visceral obesity and the metabolic syndrome.
@en
A transgenic model of visceral obesity and the metabolic syndrome.
@nl
P2093
P356
P1433
P1476
A transgenic model of visceral obesity and the metabolic syndrome.
@en
P2093
Masuzaki H
Mullins JJ
Paterson J
Shinyama H
P304
P356
10.1126/SCIENCE.1066285
P407
P577
2001-12-01T00:00:00Z